Why Argentina Works for Biotech / Life Sciences
Residency pathway breadth (91/100) gives Argentina an edge for Biotech / Life Sciences founders planning a long-term operational base. With 3 available visa programs, there are multiple entry routes depending on business stage and capital level. Citizenship by naturalization is available after 2 years. Dual citizenship is permitted. A well-defined residency ladder reduces the uncertainty that comes with multi-year business planning in a foreign jurisdiction.
Funding access (85/100) is a standout for Argentina Biotech / Life Sciences companies. The local market has 65 active VC funds, with average seed checks of $750K. Government grant programs include FONTAR R&D Grant ($200K) and FONARSEC Biotech/Nano Fund ($500K). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.
Family viability (85/100) is a genuine strength for Argentina - important for Biotech / Life Sciences founders relocating with a partner or children. The cost of living index is 50 (NYC = 100), with a comfortable family monthly budget of $4K. Safety scores 45/100. International schools are available, and healthcare quality scores 72/100 with private insurance running approximately $250/month.